1. Report on the NCI Microbial-Based Cancer Therapy Conference
- Author
-
Avraham Rasooly, Colleen S Curran, Magdelena Thurin, Ben Prickril, Min He, and Elad Sharon
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,business.industry ,Immunology ,Cancer therapy ,Cancer ,medicine.disease ,medicine.disease_cause ,Oncolytic virus ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,Medicine ,business ,Carcinogenesis - Abstract
The National Cancer Institute Inaugural Microbial-Based Cancer Therapy Conference was held in Bethesda, Maryland, on July 11–12, 2017. This interdisciplinary forum included industry leaders, academic investigators, and regulatory officers involved in the development of microbial-based therapies for the treatment of cancer. The aim of the meeting was to discuss the potential of virus- and bacteria-based therapies to halt tumorigenesis and induce immune responses in cancers where conventional therapy is inadequate. This summary highlights topics and viewpoints raised by the presenters and discussants and should not be viewed as the conclusions or recommendations of the workshop as a whole. Cancer Immunol Res; 6(2); 122–6. ©2017 AACR.
- Published
- 2018
- Full Text
- View/download PDF